⌘K

Login Start Free

Home/Filings/4/0001628280-25-007706

4//SEC Filing

HANLY ANN M. 4

Accession 0001628280-25-007706

CIK 0001706431other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 3:43 PM ET

Size

4.8 KB

Accession

0001628280-25-007706

Insider Transaction Report

Form 4

Period: 2025-02-24

Vir Biotechnology, Inc.VIR

EVP & Chief Technology Officer

Transactions

Sale
Common Stock
2025-02-24$9.45/sh−14,168$133,936→ 117,901 total

Footnotes (1)

[F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file

4
wk-form4_1740516204.xmlPrimary
FORM 4

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1

filerCIK 0001854528

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 3:43 PM ET
Size: 4.8 KB

View on SEC.gov